BRS/RA Integrated Conference |
|||
| Tuesday 13th May | |||
| 8.30 | REGISTRATION | |||
| CORPORATE SESSIONS | ||||
| 8.45 – 9.45 |
Alsh |
Boisdale |
Carron |
|
BREAKFAST |
ROCHE ERYTHROPOESIS STIMULATING AGENTS: PROCESS IS THE PRODUCT? 08.45-08.50 Welcome |
ABBOTT
NEW EMERGING ASPECTS FOR VITAMIN D RECEPTOR ACTIVATORS IN THE TREATMENT OF SHPT Invited Speaker: Daniel Zehnder , Consultant Nephrologist & Senior Clinical Lecturer, University Hospital Coventry & Warwickshire |
SANOFI AVENTIS
BLOOD PRESSURE MANAGEMENT IN RENAL DISEASE Invited Speaker: Damian Fogarty, Consultant/Senior Lecturer, Belfast City Hospital |
| 10.00- 12.00 | Lomond Auditorium CHRONIC KIDNEY DISEASE (RENAL RISK) Chairs: Paul Stevens and Peter Mathieson CKD and Progression O1The development of a sequential algorithm to assess stability of renal function in patients with CKD O2 Management of CKD at the interface between primary and secondary care: The Bradford CKD Electronic Advisory Service (CKDEAS) O3 Increased proteinuria despite equality of care in South Asians with Type 2 diabetes mellitus O4 (was 296) Prediction of End-Stage Renal Disease and Mortality among patients with pre-dialysis CKD: The Chronic Renal Impairment in Birmingham (CRIB) cohort O5 Prediction of progression of CKD within the first year post liver transplantation: defining indications for combined liver kidney transplantation 06 Tubular dysfunction with low circulating levels of Erythropoietin and 1,25 (OH) 2 D3 occurs early in Diabetics with normal GFR |
Alsh COMPLICATIONS OF DIALYTIC THERAPY Chair: Ken Farrington
O7 A collaborative approach to reducing Tunnelled HD Catheter related bacteraemia (THCRB)
O8 Clinical course and management of Encapsulating Peritoneal Sclerosis: a Multicentre Retrospective Survey by the Pan-Thames Audit Group O9 Adaptation of the ‘Derby Gentamicin/Heparin Catheter Lock Protocol’ results in a 10 fold reduction in incidence of catheter related bacteraemia O10 Peritonectomy is a successful treatment for patients with Encapsulating Peritoneal Sclerosis (EPS) following Renal Transplantation O11 Cuffed venous catheter bacteraemia – outcome after attempted salvage O12Encapsulating peritoneal sclerosis in Scotland – A retrospective case series O13 The rise of Vancomin Resistant Enterococci (VRE) in renal units O14 Serum Cardiac Troponin-T Concentrations are associated with outcome in patients with HD induced Myocardial Stunning |
Boisdale UPDATE IN TRANSPLANTATION TECHNOLOGY Chair: Roger Moore How does UK Transplant allocate donated kidneys? How do the kidneys get to the recipients? Live donor transplants – ethical issues, tissue matching, the new technology that allows transplantation despite ABO incompatibility Non-heart beating donors – logistics of providing the service and preserving the kidneys |
Carron YOUNG RENAL SCIENTIST FORUM Chair: John Reynolds and Heather Wilson Viral vectors, targeted gene therapy and kidney disease 2nd judge: Paul Evans, Senior Lecturer, National Heart & Lung Institute, Imperial College, London O15 CDP/cux is a novel modulator of collagen Type 1 and is capable of strong inhibition of the COL1A2 Gene O16 Angiopoietin-1 therapy maintains kidney peritubular capillaries but enhances fibrosis and inflammation after folic acid-induced acute renal failure O17 Role of N-methyl-D-aspartate receptor (NMDA-R) in renal epithelial-mesenchymal transition in vitro O18 The protemic analysis of rat urine following subtotal nephrectomy (SNX) O19 Aldosterone activates ERK1,2 signalling in proximal tubular epithelial cells O20 A role for diacylglycerol kinase and phosphatidyl-Inositol-3-kinase in the release of primary granules from ANCA stimulated neutrophils |
Dochart CPD SESSION – GLOMERULAR DISEASE Chairs: Jeremy Levy & Sue Carr New Developments in Treating Vasculitis Evaluation & Treatment of Steroid Resistant Nephrotic Syndrome The Podocyte; Its Failure, Its Genes and Nephrosis Interactive clinical case presentation Case Discussion with |
| 12.00-13.30 | LUNCH & EXHIBITION & CORPORATE SESSIONS | |||
| 12.15-13.15
LUNCHTIME |
Alsh ROCHE DRIVING EFFICIENCIES IN THE CARE OF DIALYSIS PATIENTS 12.15 Foreword |
Boisdale SHIRE KIDNEY CARE – ACHIEVING ADHERENCE IN PHOSPHATE MANAGEMENT 12.15 - Chairmans Introduction 12.20 - An update on Fosrenol 12.30 - Using protocols and patient group directions to 12.45 - Coaching tips for the renal healthcare 13.05 - Question and answer session |
Carron BAPN BUSINESS MEETING |
Dochart AMGEN NEW DEVELOPMENTS IN THE MANAGEMENT OF CKD PATIENTS Chair: Chris Winearls Algorithm to optimise the treatment of anaemia and the achievement of Hb stability |
| 13.30- 15.00 |
Lomond Auditorium RENOVASCULAR DISEASE - DAWN OF THE ERA OF EVIDENCE? Chairs: David Goldsmith & Alan Jardine The ASTRAL trial New Applications of MR imaging in ARVD
Prediction of renal functional outcome after revascularization in ARVD
Latest insights into the epidemiology of ARVD |
Carron IMMUNOLOGICAL RENAL DISEASE AND AKI (Renal Science) Chairs: Charles Pusey & Magdi Yaqoob O21 Renal Cell Toll-Like Receptor stimulation triggers Crescentic Glomerulonephritis O22 Slit2 impairs monocyte chemotaxis and renal expression is downregulated in acute allograft rejection O23 Acute kidney injury: Differential modulation by monocyte/macrophage depletion and apoptotic cells The Regulation of Inflammation by Ubiquitination |
| 15.00-16.00 | COFFEE & EXHIBITION MODERATED POSTER SESSION POSTERS | |
| 16.00-17.30 |
Lomond Auditorium
ASPECTS OF CKD IN PRIMARY CARE The effect of guidelines and eGFR The challenge of education: e-learning tools in CKD Emerging models of care: Where we are now, comparing differing models of care in CKD Where we should be – GP perspective |
Alsh
BRS RESEARCH FORUM Broadening Options for Long-term Dialysis in the Elderly (BOLDE): life on HD compared to PD Facilitating dietary change in renal disease; investigating patient’s perspectives A prospective randomized study to evaluate the use of pre and postoperative ultrasound in terms of predicting the maturation and patency of arteriovenous fistulae for haemodialysis The effects of oral sodium bicarbonate on extracellular water in patients with Chronic Renal Failure More time, better outcome – a randomized trial investigating the effect of more dietetic time on phosphate levels in end-stage renal failure patients |
Boisdale
RENAL REGISTRY Registry Update Pre RRT factors influencing 1st year outcomes on RRT Understanding the ‘centre’ effect Donor factors in the prediction of CKD in transplant recipients A Chairman’s mid-term viewpoint |
Carron GLOMERULAR PATHOBIOLOGY AND PROTEINURIA (Renal Science) Chair: Bruce Hendry and Moin Saleem Mesangial Cell Biology and Glomerular Disease O25 Podocyte angiopoietin-1 overexpression perturbs glomerular integrity resulting in albuminuria O26 T-Type Calcium Channel Blockade inhibits mesangial cell proliferation in vitro and in vivo O27 Angiopoietin-1 improves the ability of glomeruli to retain albumin O28 Human podocytes possess primary cilia, which may be dependent on nephrin expression for normal function and morphology |
Dochart DIALYSIS Chairs: Wendy Brown & Paul Warwicker O29 Elevated Osteoprotegrin is associated with mortality in CKD 4 and 5 patients independent of vascular calcification O30 Application of bioimpedence techniques to assess extracellular fluid status in patients attending a satellite HD unit O31 Near-subject absolute and relative measures of total body water (TBW) provide added information in the change of body composition and hydration status of HD patients over time O32 One year changes in nutritional status of patients with Encapsulating Peritoneal Sclerosis O33 Repeated episodes of HD induced Myocardial Stunning lead to Myocardial Hibernation and reduction in Overall Systolic Function O34 HD induced Myocardial Stunning is associated with a reduced 12-month survival |
| 17.45-18.45 | Lomond Auditorium Chair: Kevin Harris The impact of renal dysfunction and anaemia in CV outcome trials Invited Speaker: John McMurray, Professor of Medical Cardiology, Division of Cardiovascular Medicine, University of Glasgow | ||||
| 18.50-20.00 | WELCOME RECEPTION IN THE EXHIBITION AREA | ||||